FDA releases draft guidance for cell and gene therapies

FDA releases draft guidance for cell and gene therapies

Source: 
Biopharma Reporter
snippet: 

The FDA has released two draft guidance documents: for human gene therapy products incorporating human genome editing, and for CAR T cell products.